Ownership and insider activity for Bio-Rad Laboratories, Inc. (BIO): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics.
Price
| Price | $372.18 (closing price, October 30, 2026) |
| Market Cap | $10.0B |
| Exchange | NYSE |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-06 | Allison Schwartz | M-Exempt | 92 | |
| 2026-09-05 | Allison Schwartz | M-Exempt | 228 | |
| 2026-09-06 | Allison Schwartz | F-InKind | 34 | $13K |
| 2026-09-05 | Allison Schwartz | F-InKind | 82 | $32K |
| 2026-09-04 | Allison Schwartz | A-Award | 719 | |
| 2026-09-05 | Allison Schwartz | M-Exempt | 228 | |
| 2026-09-06 | Allison Schwartz | M-Exempt | 92 | |
| 2026-09-04 | BARRY JAMES | A-Award | 4,313 | |
| 2026-09-05 | BARRY JAMES | M-Exempt | 1,027 | |
| 2026-09-06 | BARRY JAMES | M-Exempt | 1,056 |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $456.3M | $383.8M | $431.5M | $660.7M | $662.2M | $470.8M | $434.2M | $403.8M | $488.1M | $531.8M |
| Short-term Investments | $383.2M | $371.2M | $413.3M | $454.0M | $328.9M | $399.1M | $1.36B | $1.20B | $1.18B | $1.01B |
| Receivables | $372.3M | $464.8M | $392.4M | $392.7M | $419.4M | $423.5M | $494.6M | $489.0M | $452.5M | $472.5M |
| Inventory | $525.0M | $594.8M | $583.8M | $554.0M | $622.3M | $572.2M | $719.3M | $780.5M | $760.0M | $740.7M |
| Total Current Assets | $1.84B | $1.98B | $2.02B | $2.18B | $2.14B | $1.99B | $3.16B | $3.05B | $3.03B | $2.91B |
| Property, Plant & Equipment | $488.6M | $493.5M | $508.7M | $701.2M | $693.5M | $716.4M | $679.6M | $723.7M | $688.6M | $709.9M |
| Goodwill | $477.1M | $506.1M | $219.8M | $264.1M | $291.9M | $347.3M | $406.5M | $413.6M | $410.5M | $579.8M |
| Intangible Assets | $161.6M | $174.1M | $133.1M | $145.5M | $199.5M | $253.9M | $332.1M | $320.5M | $293.6M | $174.3M |
| Total Assets | $3.85B | $4.27B | $5.61B | $8.01B | $12.97B | $17.80B | $13.50B | $12.30B | $9.36B | $10.58B |
| Accounts Payable | $133.1M | $135.2M | $122.5M | $107.0M | $139.5M | $141.9M | $135.0M | $144.6M | $122.3M | $129.0M |
| Short-term Debt | $334,000 | $420,000 | $493,000 | $425.7M | $1.3M | $489,000 | $465,000 | $500,000 | $1.2M | $37.9M |
| Total Current Liabilities | $471.3M | $502.7M | $450.8M | $905.5M | $631.5M | $680.9M | $568.7M | $522.8M | $467.8M | $517.0M |
| Long-term Debt | $434.2M | $434.6M | $438.9M | $2.4M | $1.3M | $10.5M | $1.20B | $1.20B | $1.20B | $1.34B |
| Total Liabilities | $1.27B | $1.34B | $1.59B | $2.25B | $3.09B | $4.11B | $3.89B | $3.56B | $2.79B | $3.12B |
| Retained Earnings | $1.83B | $1.83B | $3.72B | $5.47B | $9.27B | $13.53B | $9.90B | $9.26B | $7.42B | $8.18B |
| Total Equity | $2.58B | $2.93B | $4.02B | $5.76B | $9.88B | $13.69B | $9.62B | $8.74B | $6.57B | $7.45B |
| Total Debt | $434.5M | $435.0M | $439.4M | $651.2M | $225.7M | $223.4M | $1.39B | $1.41B | $1.37B | $1.53B |
| Net Debt | -$404.9M | -$320.0M | -$405.4M | -$463.5M | -$765.4M | -$646.5M | -$402.6M | -$201.6M | -$289.8M | -$11.7M |
| Working Capital | $1.37B | $1.47B | $1.57B | $1.27B | $1.51B | $1.31B | $2.59B | $2.53B | $2.56B | $2.39B |
Financial Health
| Debt / Equity | 0.17 |
| Current Ratio | 3.14 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 3.27 |
Profitability
| Return on Equity | 3.15% |
| Return on Invested Capital | 1.54% |
| Return on Assets | 2.17% |
| Gross Margin | 51.90% |
| Operating Margin | 9.08% |
| Net Margin | 8.59% |
Related companies: TECH · RGEN · BRKR · MRVI · TMO · DHR · RVTY
Explore sector: Healthcare · Medical - Devices
More sections of BIO: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks